Coeptis Pharmaceuticals, Inc. — Form D
Coeptis Pharmaceuticals, Inc. of WEXFORD, PA, a company, filed a Form D exempt-offering notice with the SEC on 2021-01-28. The offering totals $5.0M, of which $597K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2021-01-28
- Form: D
- Accession: 0001760174-21-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $597K
- Remaining: $4.4M
- Minimum investment: $10K
- Investors: 9
- Date of first sale: 2021-01-13
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-387690
Issuer
- Name: Coeptis Pharmaceuticals, Inc.
- CIK: 0001760174
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 105 BRADFORD ROAD, WEXFORD, PA, 15090
- Phone: (724) 934-6467
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| David Mehalick | Director | Naples, FL |
| Christine Sheehy | Director | Wexford, PA |
| Dan Yerace | Director | Wexford, PA |
| David Mehalick | Executive Officer | Naples, FL |
| Christine Sheehy | Executive Officer | Wexford, PA |
| Dan Yerace | Executive Officer | Wexford, PA |
| David Mehalick | Promoter | Naples, FL |
Other filings by this issuer (2)
More